Diffusion Pharmaceuticals (DFFN) Awarded Patent for Use of TSC in Conjunction with Only FDA-Approved Stroke Therapeutic
Tweet Send to a Friend
Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) announced today that it has been awarded a patent for the use of its breakthrough ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
